These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29217416)

  • 1. Identification of target proteins of clinical immunity to Plasmodium falciparum in a region of low malaria transmission.
    Sakamoto H; Takeo S; Takashima E; Miura K; Kanoi BN; Kaneko T; Han ET; Tachibana M; Matsuoka K; Sattabongkot J; Udomsangpetch R; Ishino T; Tsuboi T
    Parasitol Int; 2018 Apr; 67(2):203-208. PubMed ID: 29217416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda.
    Kanoi BN; Takashima E; Morita M; White MT; Palacpac NM; Ntege EH; Balikagala B; Yeka A; Egwang TG; Horii T; Tsuboi T
    Vaccine; 2017 Feb; 35(6):873-881. PubMed ID: 28089547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.
    Deshmukh A; Chourasia BK; Mehrotra S; Kana IH; Paul G; Panda A; Kaur I; Singh SK; Rathore S; Das A; Gupta P; Kalamuddin M; Gakhar SK; Mohmmed A; Theisen M; Malhotra P
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760216
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies against a Plasmodium falciparum RON12 inhibit merozoite invasion into erythrocytes.
    Ito D; Takashima E; Yamasaki T; Hatano S; Hasegawa T; Miura K; Morita M; Thongkukiatkul A; Diakite M; Long CA; Sattabongkot J; Udomsangpetch R; Iriko H; Ishino T; Tsuboi T
    Parasitol Int; 2019 Feb; 68(1):87-91. PubMed ID: 30342119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana.
    Amoah LE; Nuvor SV; Obboh EK; Acquah FK; Asare K; Singh SK; Boampong JN; Theisen M; Williamson KC
    Parasit Vectors; 2017 Aug; 10(1):395. PubMed ID: 28835262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
    Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
    Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
    Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
    Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-level determination of Plasmodium falciparum blood-stage targets of malarial clinical immunity in the Peruvian Amazon.
    Torres KJ; Castrillon CE; Moss EL; Saito M; Tenorio R; Molina DM; Davies H; Neafsey DE; Felgner P; Vinetz JM; Gamboa D
    J Infect Dis; 2015 Apr; 211(8):1342-51. PubMed ID: 25381370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of anti-MSP3 and Pfs230 antibody responses and multiplicity of infection in asymptomatic children from southern Ghana.
    Amoah LE; Acquah FK; Ayanful-Torgby R; Oppong A; Abankwa J; Obboh EK; Singh SK; Theisen M
    Parasit Vectors; 2018 Jan; 11(1):13. PubMed ID: 29304870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
    Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
    Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
    Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
    Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Repertoire of Human Antibodies Against
    Kanoi BN; Nagaoka H; White MT; Morita M; Palacpac NMQ; Ntege EH; Balikagala B; Yeka A; Egwang TG; Horii T; Tsuboi T; Takashima E
    Front Immunol; 2020; 11():893. PubMed ID: 32477363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya.
    Dent AE; Nakajima R; Liang L; Baum E; Moormann AM; Sumba PO; Vulule J; Babineau D; Randall A; Davies DH; Felgner PL; Kazura JW
    J Infect Dis; 2015 Nov; 212(9):1429-38. PubMed ID: 25883384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoscreening of Plasmodium falciparum proteins expressed in a wheat germ cell-free system reveals a novel malaria vaccine candidate.
    Morita M; Takashima E; Ito D; Miura K; Thongkukiatkul A; Diouf A; Fairhurst RM; Diakite M; Long CA; Torii M; Tsuboi T
    Sci Rep; 2017 Apr; 7():46086. PubMed ID: 28378857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G (IgG) specific responses to recombinant Qβ displayed MSP3 and UB05 in plasma of asymptomatic
    Ngu L; Fotso HO; Nyebe I; Tchadji JC; Ambada G; Ndah A; Atechi B; Lissom A; Atabonkeng PE; Chukwuma G; Efezeuh V; Gyu PC; Esimone C; Nguedia JCA; Akum EA; Okeke M; Titanji VPK; Mbacham W; Bopda-Waffo A; Wapimewah GN
    Pan Afr Med J; 2024; 47():175. PubMed ID: 39036016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naturally acquired immune responses to malaria vaccine candidate antigens MSP3 and GLURP in Guahibo and Piaroa indigenous communities of the Venezuelan Amazon.
    Baumann A; Magris MM; Urbaez ML; Vivas-Martinez S; Durán R; Nieves T; Esen M; Mordmüller BG; Theisen M; Avilan L; Metzger WG
    Malar J; 2012 Feb; 11():46. PubMed ID: 22335967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to the Plasmodium falciparum Proteins MSPDBL1 and MSPDBL2 Opsonize Merozoites, Inhibit Parasite Growth, and Predict Protection From Clinical Malaria.
    Chiu CY; Hodder AN; Lin CS; Hill DL; Li Wai Suen CS; Schofield L; Siba PM; Mueller I; Cowman AF; Hansen DS
    J Infect Dis; 2015 Aug; 212(3):406-15. PubMed ID: 25646353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe.
    Paul NH; Vengesai A; Mduluza T; Chipeta J; Midzi N; Bansal GP; Kumar N
    Acta Trop; 2016 Nov; 163():103-8. PubMed ID: 27491342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium falciparum malaria in children aged 0-2 years: the role of foetal haemoglobin and maternal antibodies to two asexual malaria vaccine candidates (MSP3 and GLURP).
    Kangoye DT; Nebie I; Yaro JB; Debe S; Traore S; Ouedraogo O; Sanou G; Soulama I; Diarra A; Tiono A; Marsh K; Sirima SB; Bejon P
    PLoS One; 2014; 9(9):e107965. PubMed ID: 25238160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid onset of transmission-reducing antibodies in javanese migrants exposed to malaria in papua, indonesia.
    Bousema JT; Roeffen W; van der Kolk M; de Vlas SJ; van de Vegte-Bolmer M; Bangs MJ; Teelen K; Kurniawan L; Maguire JD; Baird JK; Sauerwein RW
    Am J Trop Med Hyg; 2006 Mar; 74(3):425-31. PubMed ID: 16525101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.